Arcitumomab

A4DAB024 | Approved (w)

Target CEA/CEACAM

Isotype / Subclass G1 / None

Company

Immunomedics Giliad Sciences

Clinical Status Approved (w)

Format Whole mAb

Synonyms

—

pH Formulation —

IMGT PubChem (50070172) PubChem (135345795) PubChem (160671599) PubChem (472220672) PubChem (472399331) PubChem (480407832) PubChem (505555643) Thera-SAbDab YAbS

Avg A4D Score

-0.6774

Score Range

-0.68

Structures

Avg. A4D Score per Structure

pH at Min / Max Aggregation Propensity

Structure ID	Source PDB	Seq. Identity	Avg. A4D Score	pH (Min Agg.)	pH (Max Agg.)	Score CDR	Score non-CDR
A4DAB024_1clo_H_L	1clo	100%	-0.6774	6.5	4.0	-0.4444	-0.7057

Arcitumomab

Avg. A4D Score per Structure

pH at Min / Max Aggregation Propensity

Associated Structural Profiles Level 2